US NDA versus EU MAA eCTDs – Exploiting the Synergies and Mastering the Differences
Title: Post-Brexit 2021 – Health and Life Science Sector Impact – Legal and Regulatory Overview
Date: March 24, 2021
Time: 3 PM CET
Duration: 1 hour
Key Learnings:
- UK-EU Trade Deal: where now for healthcare & life sciences?
- Legal commentary citing common areas of concern
- Regulatory Viewpoint on key strategic and operational considerations
Speakers:
Graham Donaldson
Senior Consultant & Director, PharmaLex
Colin Kavanagh
Corporate, Commercial and Regulatory Lawyer focusing on the life sciences and communications industries, Arthur Cox
Related posts
